Early-Phase Clinical Trials | Charles River

early-phase clinical 

Comprehensive Clinical Development, formerly operating as Comprehensive NeuroScience, Inc.*, a clinical research organization delivering clinical development services from early proof-of-concept through commercialization, has acquired Charles River Clinical Services Northwest, Inc., a 250-bed, 77,000-square-foot, Phase I-IIa facility located in Tacoma, Washington.

Laboratory, Analytical & Support Services Offered by Charles River

Charles River continues to provide laboratory and analytical services to support our clients as they move through clinical development. As clinical trials begin, further in vitro and in vivo nonclinical studies performed within our global network of facilities provide additional information to support the continuation of clinical trials. Charles River is world-renowned for its developmental and reproductive toxicology and other specialty toxicology areas, such as inhalation, infusion and photobiology, all of which are supported by the largest collective group of pathologists in the industry.

 

*This web page provides hypertext links to other websites that are not owned or controlled by Charles River. These links are provided for your convenience only. These websites are controlled by third parties that Charles River does not control. Accordingly, Charles River expressly disclaims any responsibility for the content of such websites, for the accuracy or reliability of the information thereon and for the quality of products or services provided thereby or advertised thereon. No link included on this website constitutes an endorsement of Charles River of any content of, information on or product or service provided by, or advertised on, any such website. If you choose to hyperlink to another website, you do so at your own risk.



Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
May 14 - New Models for Evaluating COPD or ...
May 11 - Expert Safety Testing to Accelerat...
Jun 17-Jun 20 -  Noordwijk aan Zee, the Netherlands - 19th MDO Meeting / 12th European ...
Jun 02-Jun 05 - Vancouver, British Columbia - CALAS
Jun 05-Jun 05 - King of Prussia, Pennsylvania - Assessment of Immunomodulation for Biol...
Jun 05-Jun 08 - Saint Germain sur l’Arbresle, France - Charles River LAL Seminar Series
view all
Scientist I Wilmington, MA
Manager International Tax Wilmington, MA

Charles River Laboratories, Inc.